Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

The US isn’t guaranteed to maintain a lead over China in the race to develop artificial intelligence, according to Alphabet ...

On his second day in office, President Donald Trump unveiled a joint, private-sector venture to fund billions of dollars in U ...

CEO Sundar Pichai described current trends as "extraordinary," projecting confidence in the company's forward outlook. Wall ...

Alphabet ( GOOG 1.63%) ( GOOGL 1.58%) stock got a small lift on Tuesday, rising 2% higher through 10:30 a.m. ET. The move ...

An initiative from Google’s parent company that rushes the National Guard to climate disasters stands ready to review aerial images from the LA wildfires.

The move has been met with a mixture of cautious optimism from tech leaders and apprehension from experts concerned about the ...

Artificial intelligence (AI) was a market-driving theme last year, with AI stocks helping the S&P 500, the Nasdaq, and the ...

Analyst Justin Post of Bank of America Securities maintained a Buy rating on Alphabet Class A (GOOGL – Research Report), retaining the price ...

We recently published a list of Top 10 AI Stocks That Should Be On Your Watchlist for 2025. In this article, we are going to take a look at where Alphabet Inc. (NASDAQ:GOOG) stands against other ...

Big tech companies from Alphabet Inc. to Meta Platforms Inc. face a slate of new investor proposals to probe concerns that ...